Top 10 Companies in the 1,1‑Cyclopropanedicarboxylic Acid (CAS 598‑10‑7) Market (2026): Market Leaders Powering Global Chemical Innovation

MARKET INSIGHTS

Global 1,1‑Cyclopropanedicarboxylic acid (CAS 598‑10‑7) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4 % during the forecast period.

1,1‑Cyclopropanedicarboxylic acid is a cyclopropane‑based dicarboxylic acid compound with the molecular formula C5H6O4, characterized by a three‑membered carbocyclic ring bearing two carboxyl groups at the same carbon atom. It serves as a versatile and high‑value building block in organic synthesis, particularly in the production of pharmaceuticals, agrochemicals, and specialty chemical intermediates. Its unique strained ring structure imparts distinct reactivity, making it especially valuable in the synthesis of complex active pharmaceutical ingredients (APIs) and fine chemicals.

The market is steadily gaining traction, driven primarily by rising demand from the pharmaceutical industry for structurally constrained intermediates used in drug discovery and development. Growth in agrochemical formulations and expanding applications in specialty chemical synthesis reinforce market expansion globally. Asia‑Pacific, particularly China and India, continues to emerge as a significant production and consumption hub for this compound, supported by a robust fine chemicals manufacturing base and increasing R&D investments across the region.

1,1‑Cyclopropanedicarboxylic acid (CAS 598‑10‑7) Market – View in Detailed Research Report

Top 10 Companies in the 1,1‑Cyclopropanedicarboxylic Acid (CAS 598‑10‑7) Market (2026)

1. 1️⃣ Zibo Donghai Industry Co., Ltd. (China)

   Headquarters: Zibo, China
   Key Offering: Pharmaceutical‑grade cyclopropanedicarboxylic acid, custom synthesis services

   Zibo Donghai has established a dedicated production line that integrates advanced cyclopropanation chemistry with in‑house purification, enabling consistent delivery of high‑purity material for API development. The firm’s commitment to process scale‑up and GMP‑aligned documentation positions it as a preferred partner for contract research organizations seeking reliable supply for late‑stage synthesis.

   Sustainability & Growth Initiatives:

   • Investment in energy‑efficient cyclopropanation reactors to reduce CO₂ footprint
   • Development of solvent‑free synthesis routes to align with green chemistry mandates
   • Expansion of custom synthesis portfolio to include mono‑esters and diamides

2. 2️⃣ Hangzhou Dayangchem Co., Ltd. (China)

   Headquarters: Hangzhou, China
   Key Offering: High‑purity intermediates for pharmaceutical and agrochemical applications

   Dayangchem leverages its regional expertise in fine chemistry to provide both reagent‑grade and pharmaceutical‑grade products. Its robust quality management system ensures compliance with REACH, TSCA, and MEE, making it a trusted supplier for regulated markets.

   Sustainability & Growth Initiatives:

   • Implementation of closed‑loop water recycling in synthesis units
   • Partnerships with local universities to develop novel cyclopropane‑forming catalysts
   • Strategic procurement of low‑toxicity reagents to enhance safety profile

3. 3️⃣ Capot Chemical Co., Ltd. (China)

   Headquarters: Guangzhou, China
   Key Offering: Bulk production of cyclopropanedicarboxylic acid for specialty polymers and coatings

   Capot focuses on industrial‑grade material, providing cost‑effective solutions for high‑volume applications. The company’s scalable processes support rapid turnaround for OEM partners in the polymer sector.

   Sustainability & Growth Initiatives:

   • Adoption of low‑energy continuous‑flow synthesis to cut operating costs
   • Collaboration with material science labs to explore polymerization of the acid as a cross‑linking agent
   • Investment in waste‑valorisation of by‑products for secondary market use

4. 4️⃣ Synthonix, Inc. (USA)

   Headquarters: New York, USA
   Key Offering: Custom synthesis and analytical support for pharmaceutical R&D

   Synthonix combines synthetic expertise with state‑of‑the‑art analytical instrumentation, offering end‑to‑end solutions for medicinal chemistry teams. Its focus on rapid library generation positions it as a key enabler for fragment‑based drug discovery.

   Sustainability & Growth Initiatives:

   • Implementation of green chemistry protocols to lower solvent consumption
   • Partnerships with academia to test novel photoredox‑mediated cyclopropanation
   • Development of a digital platform for real‑time process monitoring and data sharing

5. 5️⃣ Fluorochem Ltd. (United Kingdom)

   Headquarters: Birmingham, UK
   Key Offering: High‑purity intermediates for agrochemical and specialty chemical synthesis

   Fluorochem’s reputation for rigorous quality control and compliance with UK and EU regulations makes it a go‑to supplier for regulated markets. Its portfolio includes both reagent‑grade and pharmaceutical‑grade products, catering to a broad customer base.

   Sustainability & Growth Initiatives:

   • Transition to renewable energy sources for manufacturing sites
   • Research into bio‑based feedstocks for cyclopropane precursors
   • Engagement in industry consortia to standardise impurity limits for fine chemicals

6. 6️⃣ Acros Organics (Thermo Fisher Scientific) (Belgium / USA)

   Headquarters: Waltham, USA / Leuven, Belgium
   Key Offering: Reagent‑grade cyclopropanedicarboxylic acid and analytical services

   Acros Organics supplies a wide range of laboratory‑grade reagents, backed by comprehensive analytical data. Its global distribution network ensures rapid delivery to academic and industrial customers worldwide.

   Sustainability & Growth Initiatives:

   • Integration of life‑cycle assessment in product development
   • Collaboration with suppliers to reduce hazardous waste in raw material procurement
   • Expansion of custom synthesis capabilities to meet niche market demands

7. 7️⃣ TCI Chemicals (Tokyo Chemical Industry Co., Ltd.) (Japan)

   Headquarters: Tokyo, Japan
   Key Offering: Pharmaceutical‑grade intermediates and process development services

   TCI’s focus on quality and regulatory compliance aligns with the stringent demands of the Japanese and global pharmaceutical markets. The company offers advanced process‑scale cyclopropanation chemistry and supports customers through GMP documentation.

   Sustainability & Growth Initiatives:

   • Implementation of high‑pressure, low‑volume reactors to reduce resource usage
   • Investments in catalytic cyclopropanation to enhance atom economy
   • Partnerships with research institutes to develop next‑generation cyclopropane scaffolds

8. 8️⃣ Sigma‑Aldrich (Merck KGaA) (Germany / USA)

   Headquarters: Darmstadt, Germany / St. Louis, USA
   Key Offering: Wide range of grades from reagent to pharmaceutical, with strong analytical support

   Sigma‑Aldrich’s extensive catalog and reputation for reliability make it a staple in laboratories and industrial settings. Its rigorous quality control processes ensure consistent purity across all product lines.

   Sustainability & Growth Initiatives:

   • Adoption of green chemistry guidelines across manufacturing lines
   • Development of biodegradable polymer precursors using the acid
   • Digital supply‑chain transparency to support regulatory compliance

9. 9️⃣ BASF SE (Germany)

   Headquarters: Ludwigshafen, Germany
   Key Offering: Integrated fine‑chemical production and API development services

   BASF’s global reach and expertise in process chemistry provide a solid foundation for delivering high‑quality intermediates to the pharmaceutical sector. Its focus on innovation drives continuous improvement in yield and purity.

   Sustainability & Growth Initiatives:

   • Implementation of carbon‑neutral production lines for fine chemicals
   • Research into catalyst‑driven cyclopropanation to reduce waste
   • Partnerships with pharmaceutical companies to co‑develop sustainable APIs

10. 🔟 Evonik Industries (Germany)

    Headquarters: Essen, Germany
    Key Offering: Specialty chemical intermediates with a focus on high‑performance materials and pharmaceuticals

    Evonik’s emphasis on high‑value specialty chemicals positions it as a key supplier for advanced material applications. Its robust R&D pipeline supports the development of novel cyclopropane derivatives.

    Sustainability & Growth Initiatives:

    • Investment in circular economy practices for chemical production
    • Development of bio‑based cyclopropane precursors to reduce fossil‑fuel dependency
    • Collaborations with academia to explore green synthesis routes

Download FREE Sample Report: 1,1‑Cyclopropanedicarboxylic Acid (CAS 598‑10‑7) Market

Get Full Report: 1,1‑Cyclopropanedicarboxylic Acid (CAS 598‑10‑7) Market

Outlook

The trajectory of the 1,1‑Cyclopropanedicarboxylic acid market is shaped by the continued evolution of drug discovery pipelines that prioritize three‑dimensional molecular scaffolds. As regulatory agencies worldwide tighten purity specifications, the demand for pharmaceutical‑grade material is projected to rise, supporting the expansion of dedicated production capacity in key regions such as China, India, and Europe. Concurrently, agrochemical companies seeking low‑residue, high‑efficacy active ingredients are likely to incorporate cyclopropane‑based intermediates into new crop‑protection agents, adding a secondary growth stream.

Future Trends

Emerging trends that will influence market dynamics include:

• Adoption of photoredox‑enabled cyclopropanation, which offers lower energy consumption and improved selectivity.
• Integration of digital twins for process optimization, enabling rapid scale‑up and real‑time quality control.
• Growth of green chemistry initiatives that prioritize solvent‑free and bio‑based routes, reducing the environmental footprint of intermediate synthesis.
• Expansion of specialty polymer applications where the rigid cyclopropane ring enhances material performance, opening new high‑margin avenues.